KONINKLIJKE PHILIPS NVR- NY (PHG) Fundamental Analysis & Valuation

NYSE:PHG • US5004723038

Current stock price

27.47 USD
-0.16 (-0.58%)
At close:
27.46 USD
-0.01 (-0.04%)
Pre-Market:

This PHG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PHG Profitability Analysis

1.1 Basic Checks

  • In the past year PHG was profitable.
  • PHG had a positive operating cash flow in the past year.
  • In multiple years PHG reported negative net income over the last 5 years.
  • Of the past 5 years PHG 4 years had a positive operating cash flow.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.32%, PHG is in the better half of the industry, outperforming 78.61% of the companies in the same industry.
  • PHG's Return On Equity of 8.17% is fine compared to the rest of the industry. PHG outperforms 79.14% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.79%, PHG is in the better half of the industry, outperforming 77.54% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for PHG is significantly below the industry average of 9.12%.
  • The last Return On Invested Capital (5.79%) for PHG is above the 3 year average (3.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.79%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.67%
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • The Profit Margin of PHG (5.02%) is better than 77.01% of its industry peers.
  • In the last couple of years the Profit Margin of PHG has declined.
  • PHG has a better Operating Margin (7.98%) than 75.40% of its industry peers.
  • In the last couple of years the Operating Margin of PHG has declined.
  • The Gross Margin of PHG (45.18%) is worse than 62.03% of its industry peers.
  • In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

2

2. PHG Health Analysis

2.1 Basic Checks

  • PHG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PHG has been increased compared to 1 year ago.
  • Compared to 5 years ago, PHG has more shares outstanding
  • Compared to 1 year ago, PHG has a worse debt to assets ratio.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.98 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • PHG has a Altman-Z score (1.98) which is in line with its industry peers.
  • PHG has a debt to FCF ratio of 16.37. This is a negative value and a sign of low solvency as PHG would need 16.37 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 16.37, PHG is doing good in the industry, outperforming 68.98% of the companies in the same industry.
  • PHG has a Debt/Equity ratio of 0.63. This is a neutral value indicating PHG is somewhat dependend on debt financing.
  • The Debt to Equity ratio of PHG (0.63) is worse than 67.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z 1.98
ROIC/WACC0.91
WACC6.35%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that PHG should not have too much problems paying its short term obligations.
  • PHG has a worse Current ratio (1.32) than 83.96% of its industry peers.
  • PHG has a Quick Ratio of 1.32. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of PHG (0.94) is worse than 83.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. PHG Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.11% over the past year.
  • Measured over the past years, PHG shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.62% on average per year.
  • PHG shows a decrease in Revenue. In the last year, the revenue decreased by -1.03%.
  • The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • PHG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.00% yearly.
  • The Revenue is expected to grow by 3.47% on average over the next years.
EPS Next Y3.11%
EPS Next 2Y8.19%
EPS Next 3Y10.16%
EPS Next 5Y10%
Revenue Next Year1.44%
Revenue Next 2Y2.95%
Revenue Next 3Y3.5%
Revenue Next 5Y3.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

5

4. PHG Valuation Analysis

4.1 Price/Earnings Ratio

  • PHG is valuated correctly with a Price/Earnings ratio of 15.97.
  • Based on the Price/Earnings ratio, PHG is valued cheaply inside the industry as 85.56% of the companies are valued more expensively.
  • PHG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.42, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 15.47, PHG is valued correctly.
  • PHG's Price/Forward Earnings ratio is rather cheap when compared to the industry. PHG is cheaper than 86.63% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.29. PHG is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.97
Fwd PE 15.47
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 88.77% of the companies in the same industry are more expensive than PHG, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, PHG is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 45.72
EV/EBITDA 10.94
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.13
PEG (5Y)N/A
EPS Next 2Y8.19%
EPS Next 3Y10.16%

7

5. PHG Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.32%, PHG is a good candidate for dividend investing.
  • PHG's Dividend Yield is rather good when compared to the industry average which is at 0.25. PHG pays more dividend than 98.40% of the companies in the same industry.
  • PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 4.32%

5.2 History

  • On average, the dividend of PHG grows each year by 216.55%, which is quite nice.
  • PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of PHG decreased recently.
Dividend Growth(5Y)216.55%
Div Incr Years1
Div Non Decr Years1
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2025 2026 0.5 1 1.5

5.3 Sustainability

  • PHG pays out 36.65% of its income as dividend. This is a sustainable payout ratio.
  • PHG's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.65%
EPS Next 2Y8.19%
EPS Next 3Y10.16%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

PHG Fundamentals: All Metrics, Ratios and Statistics

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (4/24/2026, 8:04:00 PM)

Premarket: 27.46 -0.01 (-0.04%)

27.47

-0.16 (-0.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners48.33%
Inst Owner Change0.32%
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap26.45B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts74.67
Price Target33.85 (23.23%)
Short Float %0.23%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield 4.32%
Yearly Dividend0.41
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)-2.68%
PT rev (3m)7.07%
EPS NQ rev (1m)-4.65%
EPS NQ rev (3m)-24.01%
EPS NY rev (1m)-0.89%
EPS NY rev (3m)-0.39%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-1.26%
Valuation
Industry RankSector Rank
PE 15.97
Fwd PE 15.47
P/S 1.27
P/FCF 45.72
P/OCF 19.44
P/B 2.06
P/tB N/A
EV/EBITDA 10.94
EPS(TTM)1.72
EY6.26%
EPS(NY)1.78
Fwd EY6.46%
FCF(TTM)0.6
FCFY2.19%
OCF(TTM)1.41
OCFY5.14%
SpS21.69
BVpS13.33
TBVpS-1.07
PEG (NY)5.13
PEG (5Y)N/A
Graham Number22.7112 (-17.32%)
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.79%
ROICexc 6.76%
ROICexgc 23.43%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.67%
ROIC(5y)N/A
ROICexc(3y)4.2%
ROICexc(5y)N/A
ROICexgc(3y)14.46%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z 1.98
F-Score7
WACC6.35%
ROIC/WACC0.91
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y3.11%
EPS Next 2Y8.19%
EPS Next 3Y10.16%
EPS Next 5Y10%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.44%
Revenue Next 2Y2.95%
Revenue Next 3Y3.5%
Revenue Next 5Y3.47%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.02%
EBIT Next 3Y26.32%
EBIT Next 5Y17.82%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NVR- NY / PHG Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


Can you provide the valuation status for KONINKLIJKE PHILIPS NVR- NY?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


What is the profitability of PHG stock?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 5 / 10.


What is the financial health of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

The financial health rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 2 / 10.


What is the earnings growth outlook for KONINKLIJKE PHILIPS NVR- NY?

The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NVR- NY (PHG) is expected to grow by 3.11% in the next year.